While the World Health Organization has put the death rate from novel coronavirus, COVID-19, at 3.4%, a study in Nature Medicine put it much lower, at 1.4%. The fact is, with many cases going unreported and untested, mild and asymptomatic cases may not be included in official COVID-19 death rate figures, which could skew the… Read More: Want to Defeat Coronavirus? Address Diabetes and Hypertension »
A study found that hypertension, a stressful job, and insufficient sleep is a combination that may increase the likelihood of dying prematurely from heart disease. If your blood pressure is elevated, it’s certainly in your best interest to do what you can to bring it down to the normal range. That will lower your risk… Read More: Hypertension and Job Stress and Poor Sleep…Oh My! »
FDA Approves Rocklatan (netarsudil and latanoprost ophthalmic solution) for the Reduction of Intraocular Pressure in Open-Angle Glaucoma or Ocular Hypertension Print this page DURHAM, N.C.–(BUSINESS WIRE)–Mar. 12, 2019– Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) (Aerie or the Company), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients… Read More: FDA Approves Rocklatan (netarsudil and latanoprost ophthalmic solution) for the… »
This book aims to present a comprehensive classification of hypertensive phenotypes based on underlying target organ involvement. Particular emphasis is placed on review and assessment of clinical presentation, pathophysiologic mechanisms, and possible specific therapeutic options for each hypertension phenotype. Several of these phenotypes are well known and well described in the literature, such as prehypertension,… Read More: Disorders of Blood Pressure Regulation: Phenotypes, Mechanisms, Therapeutic Options (Updates… »